A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Using Cardiovascular MRI
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Ranolazine (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 22 Jun 2017 Planned End Date changed from 1 May 2017 to 1 Dec 2018.
- 22 Jun 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2018.
- 19 Jul 2016 New trial record